Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 57% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
MiningAndMetalMovers.com is also looking into these tickers AVY, CMC, MERC, LIN and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Context Therapeutics, CNTX
Summary: Context Therapeutics Inc. is a women's oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. Context Therapeutics Inc. is headquartered in Philadelphia, PA.
Recent CNTX Stock Price (approx 10:00am EST.): $1.10
Previous Close for CNTX Stock:
Percentage Price Change Past 10 Days for CNTX stock:
TipRanks.com reports that Context Therapeutics stock currently has analysts offering 12-month price targets and the consensus is a Hold rating.
Click here to get the full story on CNTX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.
Recent RXRX Stock Price (approx 10:00am EST.): $8.92
Previous Close for RXRX Stock:
Percentage Price Change Past 10 Days for RXRX stock:
TipRanks.com reports that Recursion Pharmaceuticals stock currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating.
Click here to get the full story on RXRX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.
Recent RMTI Stock Price (approx 10:00am EST.): $4.06
Previous Close for RMTI Stock:
Percentage Price Change Past 10 Days for RMTI stock:
TipRanks.com reports that Rockwell Med stock currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating.
Click here to get the full story on RMTI stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
MiningAndMetalMovers.com keeps investors informed of the top moving stocks within the mining and metal sector. We provide investors with timely information regarding top moving stocks in the health tech sector sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MiningAndMetalMovers.com.
